Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 5Lymphoid 2Gynecologic 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Melanoma 386Skin Neoplasms 90Carcinoma, Non-Small-Cell Lung 78Breast Neoplasms 56Neoplasms 55Colorectal Neoplasms 52Lung Neoplasms 51Neoplasm Metastasis 46Ovarian Neoplasms 44Lymphoma, T-Cell, Cutaneous 44Carcinoma, Renal Cell 43Squamous Cell Carcinoma of Head and Neck 42Uveal Melanoma 39Pancreatic Neoplasms 37Sarcoma 35Carcinoma, Basal Cell 34Head and Neck Neoplasms 33Uterine Cervical Neoplasms 32Prostatic Neoplasms 32Stomach Neoplasms 30Carcinoma, Hepatocellular 30Endometrial Neoplasms 29Carcinoma, Merkel Cell 29Urinary Bladder Neoplasms 28Kidney Neoplasms 26Triple Negative Breast Neoplasms 24Esophageal Neoplasms 22Carcinoma, Squamous Cell 22Lymphoma 20Mycosis Fungoides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Acquired Immunodeficiency Syndrome × Dermatologic × Clear all
NCT02479698 2026-05-20

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Dermatologic

Acquired Immunodeficiency Syndrome, Neoplasms, Carcinoma, Merkel Cell, Encephalitis, Viral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡